文献速递腹部CTMR

肝脏影像报告和数据系统治疗反应算法的诊断性能:系统评价与荟萃分析

Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2021-01-06

该系统评价与荟萃分析纳入截至2020年6月1日的6项研究(453例患者,601个观察),评估LR-TR算法诊断局部区域治疗后肝细胞癌存活性的准确性。LR-TR存活类别的汇总敏感度为63%、特异度为96%;存活或不确定类别合并的敏感度为71%、特异度为87%。LR-TR存活类别特异度高但敏感度欠佳,研究间存在显著异质性,异质性与参考标准类型和研究设计显著相关。

要点

  • LR-TR存活类别诊断HCC局部治疗后存活性的汇总敏感度为63%、特异度为96%。
  • LR-TR存活或不确定类别合并的汇总敏感度为71%、特异度为87%。
  • 研究异质性显著,参考标准类型和研究设计是显著影响因素(p ≤ 0.01)。

核心结论

  • LR-TR存活类别诊断局部区域治疗后肝细胞癌存活性的特异度高,但敏感度欠佳。
  • 研究间存在显著异质性,异质性与参考标准类型和研究设计显著相关(p ≤ 0.01)。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE和EMBASE截至2020年6月1日。
  • 纳入6项报告LR-TR算法诊断准确性的原始研究,共453例患者、601个观察。
  • 纳入研究采用动态增强CT或MRI评估,采用双变量随机效应模型计算汇总敏感度和特异度。

诊断标准与关键数值

  • LR-TR存活类别:汇总敏感度63%(95%CI 39-81%;I²=88%),汇总特异度96%(95%CI 91-99%;I²=76%)。
  • LR-TR存活或不确定类别合并:汇总敏感度71%(95%CI 55-84%;I²=89%),汇总特异度87%(95%CI 73-94%;I²=80%)。
  • 仅使用MRI的研究中,LR-TR存活类别敏感度71%(95%CI 46-88%),特异度95%(95%CI 86-99%),与全体相比敏感度有升高趋势而特异度相当。

临床应用与阅片要点

  • LR-TR存活类别特异度高,阳性时对诊断HCC局部治疗后存活性的把握较大。
  • LR-TR存活类别敏感度欠佳,阴性结果不能排除存活性。
  • 将存活或不确定类别合并可提高敏感度至71%,但特异度降至87%。

局限性

  • 研究间存在显著异质性,LR-TR存活类别敏感度I²=88%、特异度I²=76%,存活或不确定类别合并敏感度I²=89%、特异度I²=80%。
  • 异质性与参考标准类型和研究设计显著相关(p ≤ 0.01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To systematically determine the accuracy of Liver Imaging Reporting and Data System treatment response (LR-TR) algorithm for diagnosing the viability of hepatocellular carcinoma (HCC) treated with locoregional therapy (LRT).

METHODS: Original studies reporting the diagnostic accuracy of LR-TR algorithm on dynamic contrast-enhanced computed tomography or magnetic resonance imaging (MRI) were identified in MEDLINE and EMBASE up to June 1, 2020. The meta-analytic summary sensitivity and specificity of LR-TR algorithm were calculated using a bivariate random-effects model. Subgroup analyses and meta-regression analysis were performed to explore study heterogeneity.

RESULTS: We found six studies reporting the accuracy of LR-TR viable category (601 observations in 453 patients). The meta-analytic pooled sensitivity and specificity of LR-TR viable category were 63% (95% confidence interval [CI], 39-81%; I2 = 88%) and 96% (95% CI, 91-99%; I2 = 76%), respectively. The meta-analytic pooled sensitivity and specificity of LR-TR viable or equivocal category combined were 71% (95% CI, 55-84%; I2 = 89%) and 87% (95% CI, 73-94% I2 = 80%), respectively. Studies which used only MRI showed a trend towards higher sensitivity (71% [95% CI, 46-88%]) with a comparable specificity (95% [95% CI, 86-99%]) of LR-TR viable category compared to the whole group. The type of reference standard and study design were significantly associated with study heterogeneity (p ≤ 0.01).

CONCLUSIONS: The LR-TR viable category had high specificity but suboptimal sensitivity for diagnosing the viability of HCC after LRT. Substantial study heterogeneity was noted, and it was significantly associated with the type of reference standard and study design.

KEY POINTS: • The meta-analytic pooled sensitivity and specificity of LR-TR viable category were 63% (95% CI, 39-81%) and 96% (95% CI, 91-99%), respectively. • The meta-analytic pooled sensitivity and specificity of LR-TR viable or equivocal category combined were 71% (95% CI, 55-84%) and 87% (95% CI, 73-94%), respectively. • The type of reference standard and study design were the factors significantly influencing study heterogeneity (p ≤ 0.01).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Youn SY, Kim DH, Choi SH, et al. Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis. Eur Radiol. 2021. PMID: 33409795. doi:10.1007/s00330-020-07464-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。